Welcome Customer !

Membership

Help

Avito (Shanghai) Pharmaceutical Technology Co., Ltd
Custom manufacturer

Main Products:

instrumentb2b>Products

Avito (Shanghai) Pharmaceutical Technology Co., Ltd

  • E-mail

  • Phone

  • Address

    Building A, 27th Floor, Huadu Building, 838 Zhangyang Road, Pudong New Area, Shanghai

Contact Now

Sucrose octasulfate sodium salt

NegotiableUpdate on 05/06
Model
Nature of the Manufacturer
Producers
Product Category
Place of Origin

Overview

Product Name Sucrose Octasulfate Sodium O11002 $r $n English Name Sucrose Octasulfate Sodium Salt $r $nCAS No. 74135-10-7 $r $n INECS No. 420-660-7 $r $n Molecular Formula C12H14Na8O35S8 $r $n Molecular Weight 1158.66 $r $n Appearance White solid powder $r $n Purity ≥ 99% r $n Solubility ≥ 100mg/mL (H2O) $r $n Melting Point 159

Product Details

Product name

Sucrose octasulfate sodium saltO11002

English name

Sucrose octasulfatesodium salt

CAS number

74135-10-7

EINECS number

420-660-7

Molecular formula

C12H14Na8O35S8

molecular weight

1158.66

structural formula

21111.png

trait

White solid powder

purity

99%

solubility

100mg/mL(H2O)

melting point

159~164

Sucrose octasulfates are a group of compounds with the structure C12H14O35S8-X8 (as shown in the figure below), where X can represent elements such as K, Na, Al, Ag, etc. In liposomes, sucrose octasulfate is mainly used in irinotecan liposomes. The use of sucrose octasulfate can make irinotecan gel or precipitate in the aqueous phase and be stably encapsulated, improving drug encapsulation efficiency. Other studies have shown that sucrose octasulfate, as an active substance in the body, can activate growth factors in the body or fibroblasts, producing a series of physiological effects. In addition, potassium sucrose octasulfate has been shown to reduce the activity of matrix metalloproteinases (MMP), stabilize growth factors, and prevent their degradation by MMP, thereby reducing wound healing time. Based on the above mechanism, sucrose octasulfate (SOS) has been applied as a new dressing in the treatment of diabetes foot, and a treatment method of sucrose octasulfate dressing mainly aimed at improving neuroischemic ulcer has also emerged in the multi center clinical trial.